Skip to Content
Stock Analyst Update

ExxonMobil Posts Strong 1Q on Rising Oil Prices

We are increasing our fair value estimate slightly to $82 from $81 for the narrow-moat firm.

Mentioned:

 Exxon Mobil (XOM) posted strong first-quarter results with gains in every segment with the exception of chemicals which saw slight declines. Total earnings surged to $4.0 billion from $1.8 billion last year on the back of the upstream segment which swung to a profit of $2.3 billion from a loss of $76 million last year thanks to improvement in oil prices. Production volumes slipped 4% largely on entitlement effects, the result of higher oil prices. Downstream earnings benefited from increased operational efficiency rising to $1.1 billion from $906 million last year. The chemicals segment was the lone outlier posting a decrease in earnings to $1.2 billion from $1.4 billion the year before on lower margins and increased turnaround activity. Cash flow of $8.9 billion including asset sale proceeds of $700 million during the quarter was more than sufficient to cover capital spending and shareholder distributions.

Exxon maintains one of the lowest dividend breakeven of the group at about $40 per barrel, ensuring its safety in almost any price environment. Dividend growth the last two years, however, has been relatively paltry compared with historical rates. For the second consecutive year, Exxon increased the dividend only 2.7%, well below the historical average of approximately 6%. We think this reflects the firm’s more cautious outlook on commodity prices and its desire to retain flexibility to make opportunistic acquisitions as opposed to the its cash flow generating ability. While its also refrained from repurchasing shares as well, we expect both dividend growth and repurchase to occur in the coming years given our forecast for increasing free cash flow.

Our fair value increases slightly to $82 from $81 after incorporating expected U.S. tax changes. Our narrow moat rating is unchanged.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Allen Good does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.